Stock Mumak

Stock Profile

Hot Mumak

Johnson & Johnson

Thanks to a strong pipeline, robust cash flows and a defensive business model, Johnson & Johnson remains a high-quality healthcare investment.

Stock Snapshot

JNJ Logo
Table HeaderTable Header
CompanyJohnson & Johnson
SectorHealthcare
ThemeQuality stock in the healthcare sector with strong dividend growth, an oncology focus, and robust financial strength.
Business ModelGlobal healthcare company with a focus on innovative medicines, oncology, immunology, and medical technology
ISINUS4781601046
Market Capitalizationapprox. $624 billion USD
UMBRELLA StatusActive

Mumak Score Card

Geopolitics

Industry

Fundamentals

Sentiment

Technical Analysis

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Johnson & Johnson
Healthcare

Valuation Analysis: Johnson & Johnson

ISIN: US4781601046

Johnson & Johnson is one of the world’s leading healthcare companies. The company benefits from a strong position in pharmaceuticals and medical technology, a robust innovation pipeline, and an exceptionally solid balance sheet.
Compass 5 out of 5
Active icon
More research

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – June 29–July 5, 2026

The healthcare sector remains in the lead, while technology and defense stocks are regaining strength. Positive impulses for the UMBRELLA
Next Update
Weekly Update

Weekly Market Overview – June 22-28, 2026

The UMBRELLA Strategy increased its focus on healthcare stocks and biotechnology. Technology showed a mixed performance, while defense stocks came
Next Update
Weekly Update

Weekly Market Overview – June 15-21, 2026

The UMBRELLA Strategy is divesting from energy stocks and further expanding its engagement in the healthcare and biotechnology sector.
Next Update
Weekly Update

Weekly Market Overview – June 8-14, 2026

AI and healthcare innovation are shaping the markets. The UMBRELLA Strategy increases its focus on quality companies and reduces cyclical
Next Update